Advertisement
News
Advertisement

The Zacks Analyst Blog Highlights: Pfizer, Bristol - Myers Squibb, Eli Lilly, Forest Laboratories and Abbott Laboratories

Thu, 12/08/2011 - 7:38am
Bio-Medicine.Org

CHICAGO, Dec. 8, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Pfizer (NYSE: PFE), Bristol - Myers Squibb (NYSE: BMY), Eli Lilly (NYSE: LLY), Forest Laboratories (NYSE: FRX) and Abbott Laboratories (NYSE: ABT).

(Logo:  http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Wednesday's Analyst Blog:

Emerging Markets: The Way Forward

According to Irish orator, philosopher, & politician Edmund Burke, change is the most powerful law of nature. The winds of change seem to be sweeping across the pharmaceutical industry as well.

Until recently, most commercialization efforts were focused on the U.S. -- the largest pharmaceutical market -- along with Europe and Japan. However, with factors like pricing pressure in the European Union (EU) and intensifying generic competition affecting sales in large pharmaceutical markets, many leading players in the pharmaceutical space such as Pfizer (NYSE: PFE), Bristol - Myers Squibb (NYSE: BMY) and Eli Lilly (NYSE: LLY) have shifted th

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading